
Brown Advisory’s West Pharmaceutical WST Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $661M | Sell |
3,021,283
-247,195
| -8% | -$54.1M | 0.87% | 29 |
|
2025
Q1 | $732M | Buy |
3,268,478
+716,442
| +28% | +$160M | 1.05% | 23 |
|
2024
Q4 | $836M | Buy |
2,552,036
+266,488
| +12% | +$87.3M | 1.06% | 24 |
|
2024
Q3 | $686M | Buy |
2,285,548
+528,153
| +30% | +$159M | 0.86% | 30 |
|
2024
Q2 | $579M | Buy |
1,757,395
+119,518
| +7% | +$39.4M | 0.76% | 36 |
|
2024
Q1 | $648M | Buy |
1,637,877
+223,446
| +16% | +$88.4M | 0.87% | 26 |
|
2023
Q4 | $498M | Buy |
1,414,431
+109,369
| +8% | +$38.5M | 0.7% | 40 |
|
2023
Q3 | $490M | Buy |
1,305,062
+35,788
| +3% | +$13.4M | 0.8% | 31 |
|
2023
Q2 | $485M | Buy |
1,269,274
+18,613
| +1% | +$7.12M | 0.76% | 34 |
|
2023
Q1 | $433M | Buy |
1,250,661
+39,220
| +3% | +$13.6M | 0.73% | 35 |
|
2022
Q4 | $285M | Sell |
1,211,441
-5,352
| -0.4% | -$1.26M | 0.53% | 51 |
|
2022
Q3 | $299M | Buy |
1,216,793
+236,270
| +24% | +$58.1M | 0.58% | 47 |
|
2022
Q2 | $296M | Sell |
980,523
-207,226
| -17% | -$62.7M | 0.56% | 47 |
|
2022
Q1 | $488M | Sell |
1,187,749
-150,842
| -11% | -$62M | 0.73% | 36 |
|
2021
Q4 | $628M | Buy |
1,338,591
+105,397
| +9% | +$49.4M | 0.78% | 34 |
|
2021
Q3 | $524M | Buy |
1,233,194
+172,183
| +16% | +$73.1M | 0.77% | 36 |
|
2021
Q2 | $381M | Sell |
1,061,011
-193,520
| -15% | -$69.5M | 0.57% | 46 |
|
2021
Q1 | $354M | Buy |
1,254,531
+82,063
| +7% | +$23.1M | 0.6% | 46 |
|
2020
Q4 | $332M | Buy |
1,172,468
+196,946
| +20% | +$55.8M | 0.59% | 46 |
|
2020
Q3 | $268M | Buy |
975,522
+120,055
| +14% | +$33M | 0.55% | 46 |
|
2020
Q2 | $194M | Buy |
855,467
+118,838
| +16% | +$27M | 0.45% | 53 |
|
2020
Q1 | $112M | Buy |
736,629
+98,474
| +15% | +$15M | 0.34% | 67 |
|
2019
Q4 | $95.9M | Buy |
638,155
+9,233
| +1% | +$1.39M | 0.24% | 90 |
|
2019
Q3 | $89.2M | Buy |
628,922
+190,868
| +44% | +$27.1M | 0.25% | 82 |
|
2019
Q2 | $54.8M | Buy |
438,054
+96,670
| +28% | +$12.1M | 0.16% | 130 |
|
2019
Q1 | $37.6M | Sell |
341,384
-231,067
| -40% | -$25.5M | 0.11% | 165 |
|
2018
Q4 | $56.1M | Buy |
572,451
+24,797
| +5% | +$2.43M | 0.19% | 98 |
|
2018
Q3 | $67.6M | Buy |
547,654
+69,424
| +15% | +$8.57M | 0.19% | 97 |
|
2018
Q2 | $47.5M | Buy |
478,230
+49,797
| +12% | +$4.94M | 0.15% | 129 |
|
2018
Q1 | $37.8M | Buy |
428,433
+301,604
| +238% | +$26.6M | 0.12% | 152 |
|
2017
Q4 | $12.5M | Buy |
126,829
+124,227
| +4,774% | +$12.3M | 0.04% | 285 |
|
2017
Q3 | $250K | Buy |
2,602
+40
| +2% | +$3.84K | ﹤0.01% | 1059 |
|
2017
Q2 | $242K | Buy |
2,562
+73
| +3% | +$6.9K | ﹤0.01% | 1085 |
|
2017
Q1 | $203K | Buy |
+2,489
| New | +$203K | ﹤0.01% | 1110 |
|